Price action
Daily adjusted bars
Snapshot
Key stats
- Market cap
- $14.74B
- P/E ratio
- 27.07
- Forward P/E
- 13.32
- Beta
- 0.48
- 52W range
- $160.86 - $250.74
- Dividend yield
- --
- Volume
- 4.87M
- Sector
- HEALTHCARE
Analyst
Consensus price target
Current
$227.28
Target
$298.26
AlphaYou verdict
Insider Cluster
C-suite + 1 other insiders bought $167K of ASND this 14d.
- Smart money5.2/40
- Fundamentals7.0/35
- Technicals1.0/15
- Macro3.3/10
Receipts
Recent signals for this ticker
- LONGJun 2Insider Cluster
C-suite + 1 other insiders bought $167K of ASND this 14d.
Public Recommendation·Checkpoints pending - LONGMay 29Insider Buy
Insider bought $95K of ASND this 14d.
Public Recommendation·Checkpoints pending
Smart money
Insider, fund, and political flow
insider buy
EVP & Chief Financial Officer SMITH SCOTT THOMAS bought $56K
insider buy
Director BIENAIME JEAN JACQUES bought $112K
insider buy
Director BIENAIME JEAN JACQUES bought $95K
short interest change
Short interest fell -22.5% as of 2026-04-30 (twice-monthly FINRA)
Top trader activity
PendingCopy-trading signal layer from real US-equity operators. Wires in once the CopyTrading feed is mapped to US-stock tickers.
BTC Astro risk regime
PendingCross-asset risk timing overlay. Used as context only, never a primary stock source.
Reputation
Sources and actors behind this ticker
Source families
- SEC EDGAR Form 4
Source family
D7
104
+2.22%
64.4% hit
D15
39
+1.87%
61.5% hit
D30
pending
Actors and filers
No mature rows yet.
Checkpoint ledger
Public recommendation outcomes
No public recommendation checkpoints have landed for this ticker yet.
D7 appears first, then D15 and D30 as the call matures.
Each row is a public recommendation. Alpha columns compare the frozen issued price with SPY, QQQ, and sector ETF checkpoints when available.
Raw source coverage
Primary-source receipt chain
Fundamentals
Valuation, quality, growth
Valuation
- P/E27.07
- Forward P/E13.32
- P/S17.02
- P/B25.62
Quality
- Profit margin57.3%
- Operating margin10.1%
- ROE33.3%
- ROA-0.6%
Growth
- Revenue YoY--
- Earnings YoY--
- Beta0.48
- Dividend yield--
Technicals
Trend, momentum, levels
Trailing returns
- 5d+1.10%
- 20d-0.62%
- 60d+0.52%
Trend vs SMAs
- vs SMA50+0.14%
- vs SMA200+0.40%
52w range position
Computed from AV daily adjusted bars. No options-flow, IV, or order-book signals on this page yet.
Macro
Sector + regime context
- +15.3
macro regime shift
VIX 15.3 (low volatility) as of 2026-05-29
- +0.5
macro regime shift
10y-2y spread 47bps (flattish) as of 2026-05-29
- +102.5
macro regime shift
Industrial Production 102.5 (mild expansion) as of 2026-04-01
- +1.0
macro regime shift
Initial claims 215,000 vs 26w mean (ratio 1.01, neutral)
- +4.0
macro regime shift
CPI YoY 3.95% (hot vs Fed target)
Earnings
EPS beat / miss history
No stored earnings history for this ticker.
The AV EARNINGS sweep backfills 8+ quarters per coverage cycle.
Debate
Key issues
Bullish view
- EVP & Chief Financial Officer SMITH SCOTT THOMAS bought $56K
- Director BIENAIME JEAN JACQUES bought $112K
- Director BIENAIME JEAN JACQUES bought $95K
- Short interest fell -22.5% as of 2026-04-30 (twice-monthly FINRA)
Bearish view
No receipts on this side yet.
Arguments are pulled from contributing receipts (Form 4 / 13F / fundamentals / macro) for this ticker. Each side carries the count of receipts behind it, not an analyst headline count.
Track record
Recommendation receipts
No D7 recommendation checkpoints landed for this ticker.
A receipt appears once a published signal hits its first walk-forward window.